F. Poggialini

发表

A Greener Technique for Microwave-Assisted O-Silylation and Silyl Ether Deprotection of Uridine and Other Substrates

E. Dreassi, A. Brai, C. Pasqualini, 2022, Chemistry.

Antibacterial alkylguanidino ureas: Molecular simplification approach, searching for membrane-based MoA.

P. Visca, E. Dreassi, L. Botta, 2022, European journal of medicinal chemistry.

(Thia)calixarenephosphonic acids as potent inhibitors of the nucleic acid chaperone activity of the HIV-1 nucleocapsid protein with a new binding mode and multi-target antiviral activity.

E. Réal, M. Botta, M. Zazzi, 2020, ACS infectious diseases.

DEAD-Box Helicase DDX3X as a Host Target against Emerging Viruses: New Insights for Medicinal Chemical Approaches.

E. Dreassi, C. Pasqualini, A. Brai, 2022, Journal of medicinal chemistry.

The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma

C. Zamperini, E. Dreassi, A. L. Fallacara, 2022, Biomedicines.

Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment.

F. Musumeci, C. Zamperini, A. L. Fallacara, 2018, Bioorganic & medicinal chemistry letters.

Discovery and Optimization of a Novel Macrocyclic Amidinourea Series Active as Acidic Mammalian Chitinase Inhibitors.

E. Dreassi, L. Botta, J. Docquier, 2023, ACS medicinal chemistry letters.

In vitro characterization, ADME analysis, histological and toxicological evaluation of BM1, a macrocyclic amidinourea active against azole-resistant Candida strains.

C. Zamperini, E. Dreassi, M. Botta, 2019, International journal of antimicrobial agents.

Tenebrio molitor as a Simple and Cheap Preclinical Pharmacokinetic and Toxicity Model

E. Dreassi, S. Simoni, V. Francardi, 2023, International journal of molecular sciences.

Progress towards Adjuvant Development: Focus on Antiviral Therapy

E. Dreassi, A. Brai, C. Pasqualini, 2023, International journal of molecular sciences.

Tyrosine Kinase Inhibitor Si409 Has In Vitro and In Vivo Anti-Tumor Activity Against Diffuse Large B-Cell Lymphoma

C. Zamperini, E. Dreassi, E. Crespan, 2023, Pharmaceutical Chemistry Journal.

Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth.

E. Dreassi, G. Giannini, A. Lapucci, 2023, Pharmacological research.

Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme

F. Musumeci, E. Dreassi, E. Crespan, 2023, Pharmaceutics.

Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: Synthesis and biological evaluation for chronic myeloid leukemia treatment.

F. Musumeci, E. Dreassi, E. Crespan, 2022, Bioorganic chemistry.

Synthesis and Antiproliferative Activity of Nitric Oxide-Donor Largazole Prodrugs.

C. Zamperini, M. Botta, V. Summa, 2020, ACS medicinal chemistry letters.

Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment

G. Damonte, F. Musumeci, E. Dreassi, 2024, Drug development research (Print).

Development and validation of derivatization-based LC-MS/MS method for quantification of short-chain fatty acids in human, rat, and mouse plasma.

E. Dreassi, C. Nicoletti, Virginia Barone, 2023, Journal of pharmaceutical and biomedical analysis.

Infesting Seaweeds as a Novel Functional Food: Analysis of Nutrients, Antioxidants and ACE Inhibitory Effects

E. Dreassi, A. Brai, F. Poggialini, 2024, International journal of molecular sciences.

Serendipitous Identification of Azine Anticancer Agents Using a Privileged Scaffold Morphing Strategy

E. Dreassi, B. M. Bizzarri, I. Vicenti, 2024, Molecules.